US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
イギリス
LSE
Lotus Bakeries NV (0F4O) 銘柄情報

Lotus Bakeries NV (0F4O)

2,330.00

0.00

(0.00%)

終了 7月7日 12:30AM

Lotus Bakeries NV (0F4O) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

2,330.00

( - )

買値

2,330.00

売値

2,330.00

出来高

26

0.00 日の範囲 0.00

2,330.00 52 週間の範囲 2,330.00

時価総額

前日終値

2,330.00

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

608 €

発行済株式数

812,053

配当利回り

90 (0.84%)

PER

55.6

1 株当たり利益 (EPS)

211.88

歳入

1.36B

純利益

172.26M

Lotus Bakeries NV, together with its subsidiaries, provides various snack products in Belgium and internationally. It offers biscuits, cookies, ginger breads, cakes, donut, waffles, pastry, fruity bakes, veggie straws, wriggles, tiddlers, biscptti, melty bittons, and pepparkakor biscuits. The compan... Lotus Bakeries NV, together with its subsidiaries, provides various snack products in Belgium and internationally. It offers biscuits, cookies, ginger breads, cakes, donut, waffles, pastry, fruity bakes, veggie straws, wriggles, tiddlers, biscptti, melty bittons, and pepparkakor biscuits. The company also provides energy bars, fruit and nut bars, protein bars, fruit and fibre bars, ice creams, and spreads. It sells its products under the Lotus, Biscoff, nakd, TREK, BEAR, Kiddylicious, Peter’s Yard, Dinosaurus, Peijnenburg, Snelle Jelle, Annas, Suzy, and Kung Oscar brands. The company was founded in 1932 and is headquartered in Lembeke, Belgium. Lotus Bakeries NV is a subsidiary of Stichting Administratiekantoor van Aandelen Lotus Bakeries. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.lotusbakeries.com

本社

Lembeke, Belgium

設立

2026

Lotus Bakeries NV is listed in the sector of the ロンドン証券取引所 with ticker 0F4O. The last closing price for Lotus Bakeries NV was 2,330.00 €. Over the last year, Lotus Bakeries NV shares have traded in a share price range of 2,330.00 € to 2,330.00 €.

Lotus Bakeries NV currently has 812,053 shares in issue. The market capitalisation of Lotus Bakeries NV is 1.89 € billion. Lotus Bakeries NV has a price to earnings ratio (PE ratio) of 55.60.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	2330	2330	2330	21	2330	DE
52	0	0	2330	2330	2330	23	2330	DE
156	0	0	2330	2330	2330	108	2330	DE
260	0	0	2330	2330	2330	186	2330	DE

0F4O - Frequently Asked Questions (FAQ)

What is the current Lotus Bakeries NV share price?

The current share price of Lotus Bakeries NV is 2,330.00 €

How many Lotus Bakeries NV shares are in issue?

Lotus Bakeries NV has 812,053 shares in issue

What is the market cap of Lotus Bakeries NV?

The market capitalisation of Lotus Bakeries NV is EUR 1.89B

What is the 1 year trading range for Lotus Bakeries NV share price?

Lotus Bakeries NV has traded in the range of 2,330.00 € to 2,330.00 € during the past year

What is the PE ratio of Lotus Bakeries NV?

The price to earnings ratio of Lotus Bakeries NV is 55.6

What is the cash to sales ratio of Lotus Bakeries NV?

The cash to sales ratio of Lotus Bakeries NV is 7.06

What is the registered address of Lotus Bakeries NV?

The registered address for Lotus Bakeries NV is Gentstraat 1, Lembeke, East Flanders, 9971

What is the Lotus Bakeries NV website address?

The website address for Lotus Bakeries NV is www.lotusbakeries.com

jack7377

jack7377 1分前

RWAX#$$: Hey Bulba and JuneBugs, the Truth and Real Reaity is by the end of September the Authorized Shares will be 95Million with an OS of 75-80Million and an additional Extension to the ent of October .-November. We ShareHolders are being Played like a Violin . The Delution-Pollution continues .

WorkinGreen

WorkinGreen 1分前

50 bagger seems conservative, but you have to start somewhere.
Step 1 - Buy 150M shares to match Emils stash
Step 2 - Wait

Mainer11185

Mainer11185 3分前

You must not be reading the SEC filings, the tests have proved that there was a reduction of viscosity. Again, it doesnt appear you are able to provide correct information, so I can't really believe anything from your position until you are able to do so.

Nytoncva

Nytoncva 4分前

Would you look at that. Corrupt agency gets the microscope on them and all the sudden there’s enough rabbit trials to approve IDE like it should have been years ago. Scumbag criminals who purposely held this and many other treatments back, to the benefit of payoffs from pharmaceutical companies sh

The-Shadow

The-Shadow 5分前

An examination of Dimension, Inc.’s latest corporate disclosures reveals their updated IP playbook. In September 2025, they were granted a new patent that changes how they are attempting to lock down upscaling and codec workflows: **U.S. Patent No. 12,432,388 (issued as US12432388B2)**, covering wha

Wizzerd

Wizzerd 5分前

I hope he read it.

mineanddine

mineanddine 5分前

Gullible chumps getting the 🖕🏿 from Emil 🤡

shurtha2000

shurtha2000 6分前

Looks like it's going back to $4

Yachtmaster

Yachtmaster 6分前

Conversely you and your team can keep pretending that the wheels are falling off this thing?
It is not an argument, what we know is fact ..
You guys can keep posting your redundant information however the investors know that what you post is BS.

Zadie420

Zadie420 8分前

I am hoping once we got approval they have PR ready to apply for other Jurisdiction(s) and start of combo trials for DCVax-D+. Then PR regarding partnership.
They have ample of time to prepare the documents for the other jurisdictions.

jman4956

jman4956 8分前

I believe your correct, and that is the plan.

Mrs kronwell

Mrs kronwell 11分前

For a point of reference- I have friends that were with Apple and Broadcom, and Nvidia (and AMD) and many more, and they’ve made 50x - 100/200x their money. In 7 yrs. I’ve been with Halo (as a retail investor) for 20 yrs. My frustration at times was 1. I missed the 200x train while faithful to Ha

US Market News

US Market News 13分前

Former FHA Commissioner Frank Cassidy Rejoins Walker & DunlopJuly 6, 2026 6:30 PM
Business Wire

US Market News

US Market News 13分前

InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4July 6, 2026 6:20 PM
Newsfile

cancerfreed

cancerfreed 13分前

U.S. FDA Approval for Investigational Device Exemption (IDE) to Initiate Human Clinical Feasibility Study for RadioGel® Precision Radionuclide Is MOST IMPORTANT. Without it, you cannot do anything. With this IDE approval, all positive human trials can be reviewed and approved by the FDA.

USVIHI22

USVIHI22 15分前

Fundamentals can lie. Math doesn't.

Genz2

Jim Cramer of Mad Money recommends Crowdstrike and Palo Alto Networks!!! Is Jim Cramer right all the time??? And what kind of expertise does Jim have in cybersecurity??? Steven K Sprague, Bill Solms and Steve Hanna are experts in cybersecurity/trusted computing!!! I would trust their thinking ov

OMOLIVES

OMOLIVES 16分前

Further...:) ...https://x.com/FDSportsbook/status/2074214297367118244

Elroy Jetson

Elroy Jetson 17分前

Reds under the bed
https://www.siliconinvestor.com/public/4188495_48c9c85bfd57e09ffe44f78ef72f6ab6.png

Kool Aid Man

Kool Aid Man 18分前

Roxanna's court testimony--.DAYUMM!!!

"I forgot I had a felony...I'm medicated...

Screenshot copies--
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177763246

My opinion--
https://investorshub.advfn.com/boards/read_msg.aspx?m

Vexari

Vexari 18分前

Hasn't worked so far
LOL Maybe he can sneak it through inspection Unless he's holding back

Waiting to flip the switch at the right time

Question is

When would that be

Old dog new trick syndrome?

Pittkid

Pittkid 18分前

Well I guess the bear(s) can put the 5k conspiracy theory to rest now! Lol

Steady_T

Steady_T 19分前

Given the way the market has responded to almost any news, saving what NWBO has to PR for post approval makes sense to me.

I suspect that approval will be met with the same efforts to control the SP that we have seen thus far. It will take a sustained PR campaign to overcome those hea

Lotus Bakeries NV

Valhalla Metals

TIME FOR FUN ON

RSE Archive (GM)

1.5% 23may2028 1.5% 23ma...

DJ Commodity Index Sugar...

Lakefront Biotherapeutic...

Invesco Canada Money Mar...

Gunnison Copper

Breakthrough Minerals

Suzuki Motor (PK)

Heatherdale Resources

Howmet Aerospace

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。